Company intelligence / Profile preview

Sun Farm Corporation

Mumbai, Maharashtra, Indiaquackwatch.org ↗

Ownership: Private
Employees: ~41000
Development stage: Other

Overview

Sun Pharma operates as one of the world’s largest specialty generic pharmaceutical companies with over $5.4 billion in annual revenue. It manufactures and sells more than 2000 products across over 100 countries. Its portfolio includes both generic and specialty branded medicines spanning multiple therapeutic areas such as dermatology (including onco‐dermatology), ophthalmology and oncology. Recent launches include Molxvir® (molnupiravir) for COVID‐19 treatment and Fexuclue® (fexuprazan) for erosive esophagitis in India.

Modalities: Small moleculeBiologicMonoclonal antibodyVaccinePeptidesProteinRecombinant protein
Industry: Biotech

Partnerships

Multiple global partnerships with academic institutions and pharma companies—specific names not detailed here.

Beyond the preview

Go deeper on Sun Farm Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sun Farm Corporation.

Explore the full profile